AI-generated summary
The authors ran a double-blind, randomised, placebo-controlled crossover study of low level laser therapy in 15 patients with primary Raynaud's phenomenon. They report that attack frequency was not significantly changed, while attacks were less intense during laser irradiation than during placebo, with effects appearing short-lived. The authors state that further studies are needed to confirm these results.
- Participants
- 15
- Who or what was studied
- Patients with primary Raynaud's phenomenon
- Limits stated in the abstract
- The abstract states that the study is small (15 patients), that further studies are needed to confirm the results, and that effects seem to be of short duration.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on econtent.hogrefe.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.